Post Laparoscopy Shoulder Pain and Postoperative Trendelenburg Position

October 15, 2019 updated by: Joseph Nassif, American University of Beirut Medical Center

Effect of Postoperative Trendelenburg Position on Shoulder Pain After Gynecological Laparoscopic Procedures.

Laparoscopic surgery has become a standard of care for many gynecological surgeries due to its lower morbidity, pain and cost compared to open techniques. Unfortunately, the use of carbon dioxide (CO2) to insufflate the abdomen is a major contributor to post operative shoulder pain. Shoulder pain post laparoscopy is common and it is a major cause of patient dissatisfaction. The aim of our study is to evaluate the efficacy of positioning the patient in Trendelenburg, post operatively for 24 hours, on shoulder pain reduction. Our hypothesis is based on the assumption that complete CO2 deflation is not possible and that Trendelenburg positioning will help displace CO2 from the sub diaphragmatic area thus reducing the diaphragmatic and phrenic nerve irritation causing pain.

Study Overview

Status

Completed

Conditions

Detailed Description

A prospective randomized controlled study with 54 patients in each of the two arms. Group S (control) will undergo the standard laparoscopic procedure and the patients will be placed in supine head up position postoperatively. In group T (interventional); the patients will be positioned in Trendelenburg position once fully awake and cooperative in the post-anesthesia case unit (PACU) and will remain in this position for the first 24 hours postoperatively. Postoperative NRS(numeric rating scale) score for shoulder pain and nausea will be collected at arrival to PACU, & 4, 6, 12 and 24 hours postoperatively. In addition, total amount of rescue pain and nausea medication used by the patient will be recorded. Data collected will be analyzed and compared between the two groups. The independent t- test will be used to compare postoperative shoulder pain, with NRS scores treated as continuous variable, between the two groups.

Study Type

Interventional

Enrollment (Actual)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beirut, Lebanon, 1103
        • American University of Beirut Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female patients
  • Age: 18 years to 60 years, American Society of Anesthesiologist physical status (ASA) 1 or 2
  • Diagnostic or operative gynecologic laparoscopy {4 port sites, three 5 mm trocars (suprapubic, right and left iliac fossa) and one 10 mm trocar (umbilical)} between one and 3 hours duration.
  • Abdominal incisions less than 1.5 cm.
  • Steady abdominal insufflation pressure of 14 mm Hg following a gradual insufflation over a 5-minute period.
  • Insufflation at a steady maximal flow of 30 l/min

Exclusion Criteria:

  • Conversion to laparotomy.
  • Abdominal insufflation pressure more than 14 mm Hg.
  • Medical drug allergy to paracetamol, ketoprofen and/or tramadol.
  • Presence of gastro-esophageal reflux (GERD)
  • Pregnancy
  • Patient with Thrombophilias and or at high risk of Deep Vein Thrombosis (DVT)
  • Obesity body mass index (BMI) greater than 40
  • One day surgery patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Group S
Control group (Group S: 54 patients); this group will undergo the standard laparoscopic procedure (the procedure is done in Trendelenburg position). While in Trendelenburg position and prior to wound closure and with laparoscopic port valves open, the patient's abdomen will be passively deflated. The patients will be placed in supine head up position in the post anesthesia care unit (PACU).
Experimental: Group T
Intervention group (Group T: 54 patients); the patients will be subject to the same maneuver as in arm 1 prior to wound closure but will be positioned in a 20 degree Trendelenburg position once fully awake and cooperative in the PACU and will remain in this position for the first 24 hours post operatively, even after they are transferred to their rooms on the American University of Beirut Medical Center (AUBMC) floors. The maximum time allowed in a straight-up position will be three 15-minute intervals over a 24-hour period (the first interval being a clear fluids intake at 12 hours postoperatively).
The patients in the intervention group will be placed in trendelenburg position postoperatively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder pain (12 hours)
Time Frame: 12 hours after laparoscopic surgery
Pain score (measured using a 0-10 numerical scale) at 12 hours
12 hours after laparoscopic surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder pain
Time Frame: at arrival to post anesthesia care unit (PACU), 4, 6, and 24 hours, after laparoscopic surgery
Pain score (measured using a 0-10 numerical scale)
at arrival to post anesthesia care unit (PACU), 4, 6, and 24 hours, after laparoscopic surgery
Presence of nausea
Time Frame: at arrival to PACU, 4, 6, 12 and 24 hours, after laparoscopic surgery
Presence or absence of nausea (yes/no)
at arrival to PACU, 4, 6, 12 and 24 hours, after laparoscopic surgery
Severity of Nausea
Time Frame: at arrival to PACU, 4, 6, 12 and 24 hours, after laparoscopic surgery
Nausea score (measured using a 0-10 numerical scale)
at arrival to PACU, 4, 6, 12 and 24 hours, after laparoscopic surgery
Rescue pain medication
Time Frame: within first 24 hours after laparoscopic surgery
Time to first rescue pain medication (minutes)
within first 24 hours after laparoscopic surgery
Total rescue pain medication
Time Frame: within first 24 hours after laparoscopic surgery
Total rescue pain medication during first 24 hours
within first 24 hours after laparoscopic surgery
Patient satisfaction
Time Frame: 24 hours post laparoscopic surgery
Patient satisfaction with surgical experience (measured using a 0-10 numerical scale)
24 hours post laparoscopic surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joseph Nassif, M.D., American University of Beirut Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

June 20, 2018

Study Completion (Actual)

June 28, 2018

Study Registration Dates

First Submitted

June 28, 2019

First Submitted That Met QC Criteria

October 15, 2019

First Posted (Actual)

October 16, 2019

Study Record Updates

Last Update Posted (Actual)

October 16, 2019

Last Update Submitted That Met QC Criteria

October 15, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Pain

Clinical Trials on 20 degree Trendelenburg position

3
Subscribe